ClinicalTrials.govpublic full text
Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes
type 2 diabetes, diabetic nephropathy, proteomics, albuminuria, sglt2 inhibitor, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 899691
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.